NCT02143401 2024-11-22
Navitoclax and Sorafenib Tosylate in Treating Patients With Relapsed or Refractory Solid Tumors
National Cancer Institute (NCI)
Phase 1 Completed
Clinical Trials
6 trialsNCT00059267 2024-11-15
Prevention of Recurrent Hepatitis B After Liver Transplantation
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Completed
NCT01350648 2024-10-01
Long-Term Study of Liver Disease in People With Hepatitis B and/or Hepatitis C With or Without HIV Infection
National Institutes of Health Clinical Center (CC)
Completed
NCT00013871 2021-11-01
Pneumococcal Vaccine and Routine Pediatric Immunizations in HIV-Infected Children Receiving Anti-HIV Drugs
National Institute of Allergy and Infectious Diseases (NIAID)
Phase NA Completed
NCT00342186 2020-06-16
Genes Involved in Resistance or Susceptibility to Hepatitis B Virus
National Institutes of Health Clinical Center (CC)
Completed
NCT01086709 2018-04-05
Crossover Vaccination of Women Previously Randomized Into Protocol 04-C-N191
National Institutes of Health Clinical Center (CC)
Completed